Skip to main content
Top
Published in: Clinical and Translational Oncology 6/2002

01-08-2002 | Originales

The prognostic value of MDM2 overexpression in superficial urothelial bladder carcinoma

Authors: Lucio Lara Santos, Marta Koch Pereira, Céu Silva Costa, Teresina Pinto Amaro, Catarina Reis Lameiras, Sofía Alves Pereira, Paula Silva Lopes, Begoña Criado Alonso, Alberto Carlos Koch, Carlos Silva Lopes

Published in: Clinical and Translational Oncology | Issue 6/2002

Login to get access
Metadata
Title
The prognostic value of MDM2 overexpression in superficial urothelial bladder carcinoma
Authors
Lucio Lara Santos
Marta Koch Pereira
Céu Silva Costa
Teresina Pinto Amaro
Catarina Reis Lameiras
Sofía Alves Pereira
Paula Silva Lopes
Begoña Criado Alonso
Alberto Carlos Koch
Carlos Silva Lopes
Publication date
01-08-2002
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2002
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02832107

Other articles of this Issue 6/2002

Clinical and Translational Oncology 6/2002 Go to the issue

Announcement

Información

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine